{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:51:07Z","timestamp":1790110267936,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2632025XCZX02"],"award-info":[{"award-number":["2632025XCZX02"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574277"],"award-info":[{"award-number":["82574277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.trsl.2026.06.006","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:36:24Z","timestamp":1781159784000},"page":"13-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["JAK2 degradation by strebloside dismantles PD-L1-mediated immune evasion in EBV-associated gastric cancer"],"prefix":"10.1016","volume":"295","author":[{"given":"Ying","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1779-1075","authenticated-orcid":false,"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2026.06.006_bib0001","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.cgh.2022.07.042","article-title":"Estimating the global burden of epstein-barr virus associated gastric cancer: a systematic review and meta-analysis","volume":"21","author":"Hirabayashi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.trsl.2026.06.006_bib0002","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2026.06.006_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1358511","article-title":"The viral etiology of EBV-associated gastric cancers contributes to their unique pathology, clinical outcomes, treatment responses and immune landscape","volume":"15","author":"Salnikov","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.06.006_bib0004","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1136\/jitc-2024-010201","article-title":"Immune microenvironment of Epstein\u2013Barr virus (EBV)-negative compared to EBV-associated gastric cancers: implications for immunotherapy","volume":"12","author":"McMiller","year":"2024","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.trsl.2026.06.006_bib0005","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0514-3","article-title":"Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer","volume":"7","author":"Mishima","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.trsl.2026.06.006_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41401-020-0366-x","article-title":"Small molecule inhibitors targeting the PD-1\/PD-L1 signaling pathway","volume":"42","author":"Wu","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.trsl.2026.06.006_bib0007","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1038\/s41467-022-29754-y","article-title":"DENR controls JAK2 translation to induce PD-L1 expression for tumor immune evasion","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2026.06.006_bib0008","article-title":"Dual regulation of gastrointestinal tumor progression by the IFN-\u03b3\/STAT1 pathway and prospects for targeted therapy","volume":"15","author":"Yuhao","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.trsl.2026.06.006_bib0009","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2026.06.006_bib0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18132-0","article-title":"IFN\u03b3 induces PD-L1 overexpression by JAK2\/STAT1\/IRF-1 signaling in EBV-positive gastric carcinoma","volume":"7","author":"Moon","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2026.06.006_bib0011","doi-asserted-by":"crossref","DOI":"10.1126\/science.ade8520","article-title":"JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma","volume":"384","author":"Zak","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.trsl.2026.06.006_bib0012","doi-asserted-by":"crossref","DOI":"10.1126\/science.adf1329","article-title":"Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients","volume":"384","author":"Mathew","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.trsl.2026.06.006_bib0013","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41392-023-01622-1","article-title":"Dynamic single-cell mapping unveils Epstein-Barr virus-imprinted T-cell exhaustion and on-treatment response","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.trsl.2026.06.006_bib0014","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3390\/v15010176","article-title":"Tumor-infiltrating t cells in EBV-associated gastric carcinomas exhibit high levels of multiple markers of activation, effector gene expression, and exhaustion","volume":"15","author":"Salnikov","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.trsl.2026.06.006_bib0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"Mikl\u00f3s","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.trsl.2026.06.006_bib0016","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12943-022-01707-5","article-title":"PROTAC\u2019ing oncoproteins: targeted protein degradation for cancer therapy","volume":"22","author":"Kelm","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.trsl.2026.06.006_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106154","article-title":"Atomic zinc sites with hierarchical porous carbon for high-throughput chemical screening with high loading capacity and stability","volume":"178","author":"Zhou","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.trsl.2026.06.006_bib0018","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/acs.jnatprod.6b01150","article-title":"+)-Strebloside-induced cytotoxicity in ovarian cancer cells is mediated through cardiac glycoside signaling networks","volume":"80","author":"Chen","year":"2017","journal-title":"J Nat Prod"},{"key":"10.1016\/j.trsl.2026.06.006_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106004","article-title":"Cardiac glycosides from the roots of Streblus asper Lour. with activity against Epstein-Barr virus lytic replication","volume":"127","author":"Cai","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.trsl.2026.06.006_bib0020","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/gutjnl-2019-320368","article-title":"Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2026.06.006_bib0021","article-title":"Association between epstein\u2013barr virus infection and PD-L1 expression in gastric cancer: prevalence, clinicopathological features, and prognostic implications","volume":"17","author":"Jirapat","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.trsl.2026.06.006_bib0022","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41590-025-02389-z","article-title":"Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy","volume":"27","author":"Alberto","year":"2026","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2026.06.006_bib0023","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev-immunol-082223-044122","article-title":"Molecular mechanisms governing CD8 T cell differentiation and checkpoint inhibitor response in cancer","volume":"43","author":"Lisa","year":"2025","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.trsl.2026.06.006_bib0024","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s10120-018-0880-4","article-title":"EBV-associated gastric cancer evades T-cell immunity by PD-1\/PD-L1 interactions","volume":"22","author":"Sasaki","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.trsl.2026.06.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101110","article-title":"DNA damage response- and JAK-dependent regulation of PD-L1 expression in head and neck squamous cell carcinoma (HNSCC) cells exposed to 5-fluorouracil (5-FU)","volume":"14","author":"Lailler","year":"2021","journal-title":"Transl Oncol"},{"key":"10.1016\/j.trsl.2026.06.006_bib0026","article-title":"Inhibition of the Na+\/K+-ATPase by cardiac glycosides suppresses expression of the IDO1 immune checkpoint in cancer cells by reducing STAT1 activation","volume":"298","author":"Mia","year":"2022","journal-title":"J Biol Chem"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:27:53Z","timestamp":1785907673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524426001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"alternative-id":["S1931524426001179"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2026.06.006","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"JAK2 degradation by strebloside dismantles PD-L1-mediated immune evasion in EBV-associated gastric cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2026.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}